Government Resources and Reports

Centers for Disease Control and Prevention: United States Cancer Statistics - This Web-based report includes the official federal statistics on cancer incidence from registries that have high-quality data and cancer mortality statistics. It is produced by the Centers for Disease Control and Prevention (CDC) and the National Cancer Institute (NCI).

Centers for Disease Control and Prevention: Health, United States - Compiled by the CDC's National Center for Health Statistics, the Health, United States series presents an annual overview of national trends in health statistics.

Medicare.gov: Medicare & You 2024 - The official U.S. government Medicare handbook.

National Cancer Institute Surveillance, Epidemiology, and End Results Program (SEER) Publications - Read about a variety of national cancer statistics.

NJ Health: NJ State Cancer Registry Reports - Choose from an extensive list of current and historical New Jersey cancer statistics.

NJ Health: Office of Cancer Control and Prevention - The State of New Jersey Department of Health provides this listing of cancer and wellness resources that can be found in NJ.

NJ State Cancer Registrry - New Jersey's official source for cancer statistics, provides cancer incidence and mortality data for New Jersey displayed in maps, tables, and graphs. 

U.S. Department of Health and Human Services Health Resources and Services Administration: Transplant Outcomes - These reports show patient survival and transplant data of bone marrow and umbilical cord blood transplants in the transplant outcomes registry of the C.W. Bill Young Cell Transplantation Program, also called the Stem Cell Therapeutic Outcomes Database.

U.S. Department of Health and Human Services National Toxicology Program: Report on Carcinogens - The Report on Carcinogens (RoC) is a congressionally mandated, science-based, public health document that the NTP prepared for the HHS Secretary. It identifies agents, substances, mixtures, and exposure circumstances that are known or reasonably anticipated to cause cancer in humans.
 

April 2024